• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5074864)   Today's Articles (211)
For: Shibamoto Y, Zhou L, Hatta H, Mori M, Nishimoto S. A novel class of antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), that releases 5-fluorouracil upon hypoxic irradiation. Jpn J Cancer Res 2000;91:433-8. [PMID: 10804292 PMCID: PMC5926472 DOI: 10.1111/j.1349-7006.2000.tb00963.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]  Open
Number Cited by Other Article(s)
1
Fu Q, Gu Z, Shen S, Bai Y, Wang X, Xu M, Sun P, Chen J, Li D, Liu Z. Radiotherapy activates picolinium prodrugs in tumours. Nat Chem 2024;16:1348-1356. [PMID: 38561425 DOI: 10.1038/s41557-024-01501-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Accepted: 03/05/2024] [Indexed: 04/04/2024]
2
Synthesis and properties of fluorinated uracils as promising drugs for medicine. Russ Chem Bull 2022. [DOI: 10.1007/s11172-022-3370-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
3
Liu CD, Wang JH, Xie Y, Chen H. Synthesis and DNA/RNA complementation studies of peptide nucleic acids containing 5-halouracils. MEDCHEMCOMM 2017;8:385-389. [PMID: 30108754 PMCID: PMC6071789 DOI: 10.1039/c6md00536e] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/23/2016] [Accepted: 12/09/2016] [Indexed: 01/02/2023]
4
Tanabe K, Ebihara M, Hirata N, Nishimoto SI. Radiolytic one-electron reduction characteristics of tyrosine derivative caged by 2-oxopropyl group. Bioorg Med Chem Lett 2008;18:6126-9. [PMID: 18930655 DOI: 10.1016/j.bmcl.2008.10.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2008] [Revised: 10/02/2008] [Accepted: 10/03/2008] [Indexed: 10/21/2022]
5
Ito T, Tanabe K, Yamada H, Hatta H, Nishimoto SI. Radiation- and photo-induced activation of 5-fluorouracil prodrugs as a strategy for the selective treatment of solid tumors. Molecules 2008;13:2370-84. [PMID: 18830160 PMCID: PMC6245186 DOI: 10.3390/molecules13102370] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2008] [Revised: 09/22/2008] [Accepted: 09/22/2008] [Indexed: 12/02/2022]  Open
6
Tanabe K, Hirata N, Harada H, Hiraoka M, Nishimoto SI. Emission under hypoxia: one-electron reduction and fluorescence characteristics of an indolequinone-coumarin conjugate. Chembiochem 2008;9:426-32. [PMID: 18224643 DOI: 10.1002/cbic.200700458] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
7
Singh Y, Palombo M, Sinko PJ. Recent trends in targeted anticancer prodrug and conjugate design. Curr Med Chem 2008;15:1802-26. [PMID: 18691040 PMCID: PMC2802226 DOI: 10.2174/092986708785132997] [Citation(s) in RCA: 164] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
8
Wouters A, Pauwels B, Lardon F, Vermorken JB. Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. Oncologist 2007;12:690-712. [PMID: 17602059 DOI: 10.1634/theoncologist.12-6-690] [Citation(s) in RCA: 97] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]  Open
9
Tanabe K, Kanezaki H, Ishii H, Nishimoto SI. 2-Oxoalkyl caged oligonucleotides: one-electron reductive activation into emergence of ordinary hybridization property by hypoxic X-irradiation. Org Biomol Chem 2007;5:1242-6. [PMID: 17406722 DOI: 10.1039/b618810a] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
10
Tanabe K, Zhang Z, Ito T, Hatta H, Nishimoto SI. Current molecular design of intelligent drugs and imaging probes targeting tumor-specific microenvironments. Org Biomol Chem 2007;5:3745-57. [DOI: 10.1039/b711244k] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
11
Tanabe K, Makimura Y, Tachi Y, Imagawa-Sato A, Nishimoto SI. Hypoxia-selective activation of 5-fluorodeoxyuridine prodrug possessing indolequinone structure: radiolytic reduction and cytotoxicity characteristics. Bioorg Med Chem Lett 2005;15:2321-4. [PMID: 15837317 DOI: 10.1016/j.bmcl.2005.03.013] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2004] [Accepted: 03/01/2005] [Indexed: 10/25/2022]
12
Denny WA. Tumor-activated prodrugs--a new approach to cancer therapy. Cancer Invest 2004;22:604-19. [PMID: 15565818 DOI: 10.1081/cnv-200027148] [Citation(s) in RCA: 116] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
13
Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004;4:437-47. [PMID: 15170446 DOI: 10.1038/nrc1367] [Citation(s) in RCA: 2056] [Impact Index Per Article: 97.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
14
Shibamoto Y, Jeremic B. Biologic premises of combined radiation therapy and chemotherapy in lung cancer. Hematol Oncol Clin North Am 2004;18:29-40. [PMID: 15005279 DOI: 10.1016/s0889-8588(03)00151-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
15
Shibamoto Y, Tachi Y, Tanabe K, Hatta H, Nishimoto SI. In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2′-deoxyuridine activated by hypoxic irradiation. Int J Radiat Oncol Biol Phys 2004;58:397-402. [PMID: 14751508 DOI: 10.1016/j.ijrobp.2003.09.048] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
16
Denny WA. The Design of Drugs that Target Tumour Hypoxia. Aust J Chem 2004. [DOI: 10.1071/ch04051] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
17
Tanabe K, Mimasu Y, Eto A, Tachi Y, Sakakibara S, Mori M, Hatta H, Nishimoto SI. One-Electron reduction characteristics of N(3)-Substituted 5-fluorodeoxyuridines synthesized as radiation-Activated prodrugs. Bioorg Med Chem 2003;11:4551-6. [PMID: 14527551 DOI: 10.1016/j.bmc.2003.08.001] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
18
Shibamoto Y, Mimasu Y, Tachi Y, Hatta H, Nishimoto S. Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugs. J Chemother 2002;14:390-6. [PMID: 12420858 DOI: 10.1179/joc.2002.14.4.390] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
19
Shibamoto Y, Zhou L, Hatta H, Mori M, Nishimoto SI. In vivo evaluation of a novel antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), which releases 5-fluorouracil upon hypoxic irradiation. Int J Radiat Oncol Biol Phys 2001;49:407-13. [PMID: 11173134 DOI: 10.1016/s0360-3016(00)01490-5] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA